The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.
The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.
Key Challenges
Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.
Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.
“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”
Opportunities
The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.
Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:
Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.
Conclusion
The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.
Plant phenotyping refers to a set of methods and tools used to measure plant characteristics or phenotypes such as height, color, etc. Phenotypes are affected by environmental factors and interactions between genes. The knowledge of phenotypic characteristics of a pla... View more
Genomic biomarkers are indicators based on gene expression, gene mutation, gene regulation, and other gene characteristics that can be measured for clinical diagnosis. Genomic biomarkers can be used to detect neurological, oncological, and cardiovascular diseases. Gen... View more
Cardiac markers are used for the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS) and for management and prognosis in patients with acute heart failure, pulmonary embolism, and other disease states. ... View more
Antifreeze proteins are capable of binding to ice by the phenomenon of adsorption and stopping the growth of ice crystals. This special property of antifreeze proteins finds its use in a variety of applications such as in food & beverage industry, medical industry... View more
Blood and blood components are clinically used for blood transfusion to provide life-saving intervention to patient suffering from bleeding disorders, traumatic surgery, chronic diseases or rare blood diseases. Some of the bleeding disorders, which require blood trans... View more
The coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as a pandemic on March 11, 2020. COVID-19 infection is caused by the novel SARS-CoV-2, which is a member of single stranded RN... View more
Gene panel test is a genetic testing tool which sequences the whole genome of the patient suspected to be suffering from diseases caused due to genetic mutations or are genetically inherited such as cancer, cardiovascular diseases, and others. Few applications of gene... View more
Biologics are the latest treatment used in clinical studies, particularly in orthopedic surgery. Spine biologics are biomaterials that alter the surroundings through their active cellular processes that promote growth and differentiation, thereby assisting in the repa... View more
Amniotic membrane is the innermost layer of fetal membrane which is extracted from placenta of women and harvested to be used as a transplant material for reconstructive surgery for cases such as severely burnt skin, trauma wounds, chronic wounds and others. Amniotic ... View more
Combination vaccine couples two or more vaccines into a single vaccine shot which allows the user to get only a few shots for a number of diseases. For instance, MMR vaccine provides protection against three diseases viz. measles, mumps, and rubella. In addition, MMRV... View more
Industrial microbiology uses different microorganisms such as naturally occurring organisms, laboratory selected mutants, or even genetically modified organisms to produce a large variety of industrial products in large quantities. Industrial microbiology is a branch ... View more
Biologics or biological products are medicines made from living organisms through highly complex manufacturing processes, and must be handled and administered under carefully monitored conditions. Biologics include a wide variety of products such as gene and cell ther... View more
Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines. Under such severe conditions, transplants remain the component for restoration of healthy life. ... View more
Platelet concentration systems are designed for safe and rapid preparation of platelet rich plasma at the point-of-care from a small amount of patient’s blood sampl... View more
As coronavirus cases continue to prevail across the globe, vaccination is expected to be the best method to control the rising cases. According to the World health Organization (WHO), as on May 13, 2021, there are at least 13 different vaccines such as Pfizer/BioNTech... View more
Artificial sperms are the artificial spermatozoa for individuals suffering from infertility. In fertile males, the spermatozoa is developed by mitosis, meiosis, and maturation in male gonad (testis) and the process is known as spermatogenesis. Males suffering from inf... View more
Oligonucleotides are short DNA or RNA molecules and have specific sequence of nucleotide residue, which makes an entire molecule. Oligonucleotides readily bind in specific sequencing manner to their respective DNA-RNA oligonucleotide to form duplex chain. Oligonucleot... View more
Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells. Sta... View more
Contact Us